The United States is poised to get a third coronavirus vaccine -- this one made by Johnson & Johnson. The US Food and Drug Administration has given the vaccine emergency use authorization, the Centers ...

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...

Johnson & Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September. The company said it has selected a lead vaccine candidate from constructs it's been working ...

NEW YORK (WABC) -- A CDC panel will meet this week to discuss recommendations for Moderna and Johnson and Johnson COVID-19 vaccine boosters. The meetings come after after an FDA advisory panel made ...

On Saturday, Johnson & Johnson's Covid vaccine gained emergency use authorization by the Food and Drug Administration, making it the third coronavirus vaccine available in the United States. In the ...

The Johnson & Johnson COVID-19 vaccine is now the third approved for emergency use authorization in the United States, and it's a little different from its predecessors. SciShow is supported by ...

NEW BRUNSWICK, N.J. -- Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company ...

Nearly 4 million doses of Johnson & Johnson's single-dose COVID-19 vaccine are headed to states, including California, with injections expected to start as early as Tuesday. The White House says the ...

PHILADELPHIA (WPVI) -- We could soon be getting much closer to having a third coronavirus vaccine authorized here in the United States. Early results from the Johnson & Johnson's vaccine trials look ...

RALEIGH, N.C. (WTVD) -- Here are the latest updates about COVID-19, the disease caused by the novel coronavirus, in North Carolina. 5:57 p.m. Wake County Public Health will explore feelings of ...

SAN FRANCISCO -- Herculean efforts by scientists and physicians around the world have resulted more than 50 experimental COVID-19 vaccines currently in global clinical trials. The focus in the U.S.